A Phase I, Multicenter Study of CD4- directed chimeric antigen receptor engineered T-cells (CD4CAR) in patients with Relapsed or Refractory CD4+ Lymphoid Hematological Malignancies
Protocol No. | CTO-IUSCCC-ICG122-101 | Scope | National |
---|---|---|---|
Principal Investigator | Huda Salman | Treatment Type | Treatment |
Age Group | Adult | Phase | Phase I |